Schedule 13G ownership disclosure

REIN THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 00887A204

Event date: 2024-11-04

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO

    Shares: 960,665.00 · Class: 4.4%

  • The Board of Regents of the University of Texas System

    Shares: 960,665.00 · Class: 4.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019231-24-000036
Form type
SCHEDULE 13G/A
Filer
Rein Therapeutics, Inc.
CIK
CIK 1420565
Filed
Nov 05, 2024
Reporting period
Nov 04, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub